Anaphylaxis

Food Allergy

Seasonal Allergy

Allergy

Biosimilars

Arrhythmia

Atherosclerotic Cardiovascular Disease

Dyslipidemia

Heart Failure

Hypertension

Lipid Management

Stroke

Structural Heart Disease

Venous Thromboembolism

Cardiology

Acne

Atopic Dermatitis

Chronic Idiopathic Urticaria

Plaque Psoriasis

Rosacea

Vitiligo

Dermatology

Hormonal Disorders

Polycystic Ovary Syndrome

Thyroid Disorders

Type 1 Diabetes

Type 2 Diabetes

Endocrinology

FDA News

COVID-19

Influenza

Vaccination

Family Medicine

C Difficile Infection

Gastroesophageal Reflux Disease (GERD)

Inflammatory Bowel Disease

Irritable Bowel Syndrome

Peptic Ulcer

Ulcerative Colitis

Gastroenterology

Alzheimer Disease

Parkinson Disease

Geriatrics

Anemia

Sickle Cell

Hematology

Hepatitis C

MASH / MASLD

Hepatology

Hospital Medicine

HIV/AIDS

Infectious Disease

Internal Medicine

Chronic Kidney Disease

IgA Nephropathy

Nephrology

Epilepsy

Migraine

Tardive Dyskinesia

Traumatic Brain Injury

Neurology

Obesity Management

Age-Related Macular Degeneration

Diabetic Macular Edema

Geographic Atrophy

Uveitis

Ophthalmology

Acute Pain

Chronic Pain

Multiple Sclerosis

Neuropathic Pain

Pain

Pediatrics

ADHD

Addiction

Bipolar Disorder

Major Depressive Disorder

PTSD

Schizophrenia

Psychiatry

Asthma

COPD

Lung Cancer

Pulmonary Fibrosis

Pulmonology

Amyloidosis

Huntington Disease

Lysosomal Storage Disorders

Vasculitis

Rare Disease Report®

Ankylosing Spondylitis

Fibromyalgia

Gout

Lupus

Non-radiographic Axial Spondyloarthritis

Osteoarthritis

Osteoporosis

Psoriatic Arthritis

Rheumatoid Arthritis

Spondyloarthritis

Rheumatology

Insomnia

Obstructive Sleep Apnea

Sleep

Plastic surgery

Surgery

Women's Health

News

Media

Medical World News

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

CURE Connections®

Insights

Medcast Podcasts

Medcast Videos

News Network

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Interactive Tools

Live Events

Press Release

Publications

Advisory Board

Subscribe

In an interview with HCPLive, Larry Ereshefsky, PharmD discussed the phase 3 RECOVER trial assessing brilaroxazine at 50 mg and 15 mg for acute schziophrenia.

  Phase 3 Data on Brilaroxazine for Schizophrenia with Larry Ereshefsky, PharmD

Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Articles

Study Details Epitope Binding, Efficacy of IL-23 Inhibitors in Plaque Psoriasis

Abigail Brooks is an assistant editor for 

She joined MJH Life Sciences in August 2023 shortly after graduating from Monmouth University where she earned her BA in Communication with a concentration in Public Relations/Journalism and later an MA in Interactive Digital Media. She enjoys traveling, running, and reading books. She can be reached at abrooks@mjhlifesciences.com.

Solomon explains how the health care system contributes to climate change and the direct health impacts seen as a result, based on her session at ACP.

Caren Solomon, MD, MPH: Health Impacts of Climate Change, Health Care’s Contribution

Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.

Treatment with risankizumab was shown to be an effective strategy among patients with PsA regardless of varying demographic and psoriatic disease characteristics through 1 year. 

Long-term Risankizumab Treatment Outperforms Placebo in PsA 

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

Frank Armstrong

Articles